Global market for stem cells to reach $10.6 billion by 2018

August 6, 2014

Stem cell technology, among all other areas of bioscience, has produced a number of significant products in important therapeutic areas since the last decade. Because of the massive size of the market, developing a stem cell product line represents a considerable financial opportunity for research supply companies along with institutes involved in therapy and stem cord banking. With its global market expanding by double-digit every year, the stem cell market is estimated to grow substantially in the near future.

BCC Research provides an in-depth study of the global stem cells market through its report, The Global Market for Stem Cells. According to the report, the global market for stem cells reached $5.6 billion in 2013 and is expected to reach $6.2 billion in 2014. This is expected to grow to $10.2 billion by 2018, with a compound annual growth rate (CAGR) of 13.6% from 2013 to 2018.

RSS Feeds – Biotechnology

Use this report for, but not limited to, the following reasons:

  • Gain an overview of the global market for stem cells and related technologies
  • Analyze global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019
  • Access information on the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market
  • Examine strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market
  • Review comprehensive profiles of major players in the field
SAMPLE FIGURE
GLOBAL STEM CELL MARKET AND FORECASTS, 2012-2018
($ MILLIONS)

1406792432_BIO035E-0

To order your copy of this report (or any of its chapters) or to download the report overview, click here.

Advertisements

US market for stem cell technologies in next 5 years

August 12, 2008

According to a new technical market research report, STEM CELL TECHNOLOGY: CURRENT APPLICATIONS AND FUTURE DIRECTIONS (BIO035C) from BCC Research, the domestic market for stem cell technology is expected to increase from $112.0 million in 2007 to $423.1 million in 2012, a compound annual growth rate (CAGR) of 30.5%

The market is divided into cellular therapeutics and therapeutic banking categories. Stem cells in therapeutic banking have the larger share of the market, worth $65.9 million in 2007 and expected to increase to $155.7 million in 2012, for a CAGR of 18.8%.

Cellular therapeutics should be the faster growing segment. Cellular therapeutics generated $46.1 million in 2007 and is expected to generate $267.4 million in 2012, a CAGR of 42.1%.

read more | digg story

Bookmark and Share